WallStreetZenWallStreetZen

NASDAQ: EKSO
Ekso Bionics Holdings Inc Stock

Open Broker Account
$1.48+0.01 (+0.68%)
Updated Dec 9, 2022
EKSO Price
$1.48
Fair Value Price
$3.71
Market Cap
$19.45M
52 Week Low
$1.03
52 Week High
$3.24
P/E
-1.29x
P/B
0.68x
P/S
1.52x
PEG
N/A
Dividend Yield
N/A
Revenue
$13.44M
Earnings
-$14.77M
Gross Margin
51.7%
Operating Margin
-108.95%
Profit Margin
-109.9%
Debt to Equity
0.37
Operating Cash Flow
-$14M
Beta
0.66
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

EKSO Overview

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.

Zen Score

Industry Average (33)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EKSO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

EKSO ($1.48) is undervalued by 60.13% relative to our estimate of its Fair Value price of $3.71 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
EKSO ($1.48) is significantly undervalued by 60.13% relative to our estimate of its Fair Value price of $3.71 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
EKSO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more EKSO due diligence checks available for Premium users.

Be the first to know about important EKSO news, forecast changes, insider trades & much more!

EKSO News

Valuation

EKSO fair value

Fair Value of EKSO stock based on Discounted Cash Flow (DCF)
Price
$1.48
Fair Value
$3.71
Undervalued by
60.13%
EKSO ($1.48) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
EKSO ($1.48) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
EKSO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

EKSO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.29x
Industry
-74.44x
Market
21.21x

EKSO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.68x
Industry
3.56x
EKSO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

EKSO's financial health

Profit margin

Revenue
$3.3M
Net Income
-$4.3M
Profit Margin
-129.3%
EKSO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
EKSO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$39.3M
Liabilities
$10.7M
Debt to equity
0.37
EKSO's short-term assets ($36.75M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EKSO's short-term assets ($36.75M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EKSO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EKSO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.6M
Investing
$0.0
Financing
$0.0
EKSO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

EKSO vs Medical Stocks

TickerMarket Cap1d %P/EP/B
EKSO$19.45M+0.68%-1.29x0.68x
ECOR$22.42M+15.38%-1.02x1.01x
GCTK$25.07M0.00%-5.59x10.65x
FEMY$12.76M0.00%-1.37x0.71x
NURO$12.30M+0.32%-2.23x0.56x

Ekso Bionics Holdings Stock FAQ

What is Ekso Bionics Holdings's quote symbol?

NASDAQ: EKSO) Ekso Bionics Holdings trades on the NASDAQ under the ticker symbol EKSO. Ekso Bionics Holdings stock quotes can also be displayed as NASDAQ: EKSO.

If you're new to stock investing, here's how to buy Ekso Bionics Holdings stock.

What is the 52 week high and low for Ekso Bionics Holdings (NASDAQ: EKSO)?

(NASDAQ: EKSO) Ekso Bionics Holdings's 52-week high was $3.24, and its 52-week low was $1.03. It is currently -54.32% from its 52-week high and 43.69% from its 52-week low.

How much is Ekso Bionics Holdings stock worth today?

(NASDAQ: EKSO) Ekso Bionics Holdings currently has 13,142,418 outstanding shares. With Ekso Bionics Holdings stock trading at $1.48 per share, the total value of Ekso Bionics Holdings stock (market capitalization) is $19.45M.

Ekso Bionics Holdings stock was originally listed at a price of $257.25 in Jan 17, 2014. If you had invested in Ekso Bionics Holdings stock at $257.25, your return over the last 8 years would have been -99.42%, for an annualized return of -47.52% (not including any dividends or dividend reinvestments).

How much is Ekso Bionics Holdings's stock price per share?

(NASDAQ: EKSO) Ekso Bionics Holdings stock price per share is $1.48 today (as of Dec 9, 2022).

What is Ekso Bionics Holdings's Market Cap?

(NASDAQ: EKSO) Ekso Bionics Holdings's market cap is $19.45M, as of Dec 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ekso Bionics Holdings's market cap is calculated by multiplying EKSO's current stock price of $1.48 by EKSO's total outstanding shares of 13,142,418.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.